SCHEMBL25536576

SCHEMBL25536576

CC1(C)c2cccc(-c3ccc(-c4cc(-c5ccc(-c6ccc7ccccc7c6)cc5)nc(-c5ccccc5)n4)c4ccccc34)c2-c2c1ccc1ccccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 1/20 0.38
CYP1B1 Q16678 1/20 0.38
PIM1 P11309 1/20 0.37
MEN1 O00255 6/20 0.34
KMT2A Q03164 6/20 0.34
ALDH1A1 P00352 6/20 0.34
MAPT P10636 5/20 0.34
HPGD P15428 5/20 0.34
NTSR1 P30989 1/20 0.34
KDM4E B2RXH2 4/20 0.34
LMNA P02545 1/20 0.34
GLA P06280 1/20 0.34
MAOB P27338 3/20 0.34
MAOA P21397 2/20 0.34
CTRC Q99895 1/20 0.33
HSD17B1 P14061 1/20 0.33
HSD17B2 P37059 1/20 0.33
BRD4 O60885 1/20 0.32
ACACA Q13085 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25538246 0.97 PIM1 (0.40) CYP1A1CYP1B1PIM1MEN1KMT2A
SCHEMBL25536579 0.96 PIM1 (0.39) CYP1A1CYP1B1PIM1MEN1KMT2A
SCHEMBL25536574 0.96 PIM1 (0.40) CYP1A1CYP1B1PIM1MEN1KMT2A
SCHEMBL25537763 0.96 PIM1 (0.40) CYP1A1CYP1B1PIM1MEN1KMT2A
SCHEMBL25536659 0.96 MEN1 (0.36) PIM1MEN1KMT2AALDH1A1MAPT
SCHEMBL25538238 0.96 MEN1 (0.37) CYP1A1CYP1B1PIM1MEN1KMT2A
SCHEMBL25536556 0.96 MEN1 (0.37) CYP1A1CYP1B1PIM1MEN1KMT2A
SCHEMBL25537756 0.96 MEN1 (0.37) CYP1A1CYP1B1PIM1MEN1KMT2A
SCHEMBL25536561 0.96 MEN1 (0.37) CYP1A1CYP1B1PIM1MEN1KMT2A
SCHEMBL25538237 0.96 MEN1 (0.37) CYP1A1CYP1B1PIM1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM CYP1A1 888/4885CYP1B1 1273/4885PIM1 1763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.